mint - Science
DCGI sees Merck drug less effective against moderate Covid: Report
Aurobindo Pharma Ltd wants to discontinue a late-stage trial of Merck drug in moderate Covid-19 patients, DCGI's expert committee said on Friday
from mint - Science https://ift.tt/3uRv7Sz
from mint - Science https://ift.tt/3uRv7Sz
Post a Comment
0 Comments